Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Kuhlen, Michaela; Willasch, Andre M; Dalle, Jean-Hugues; Wachowiak, Jacek; Yaniv, Isaac; Ifversen, Marianne; Sedlacek, Petr; Güngör, Tayfun; Lang, Peter; Bader, Peter; Sufliarska, Sabina; Balduzzi, Adriana; Strahm, Brigitte; von Luettichau, Irene; Hoell, Jessica I; Borkhardt, Arndt; Klingebiel, Thomas; Schrappe, Martin; von Stackelberg, Arend; Glogova, Evgenia; Poetschger, Ulrike; Meisel, Roland; Peters, Christina (2018). Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial. British Journal of Haematology, 180(1):82-89.

Preuner, Sandra; Peters, Christina; Pötschger, Ulrike; Daxberger, Helga; Fritsch, Gerhard; Geyeregger, Rene; Schrauder, André; von Stackelberg, Arend; Schrappe, Martin; Bader, Peter; Ebell, Wolfram; Eckert, Cornelia; Lang, Peter; Sykora, Karl-Walter; Schrum, Johanna; Kremens, Bernhard; Ehlert, Karoline; Albert, Michael H; Meisel, Roland; Lawitschka, Anita; Mann, Georg; Panzer-Grümayer, Renate; Güngör, Tayfun; Holter, Wolfgang; Strahm, Brigitte; Gruhn, Bernd; Schulz, Ansgar; Woessmann, Wilhelm; Lion, Thomas (2016). Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia. Haematologica, 101(6):741-746.

McComb, Scott; Aguadé-Gorgorió, Júlia; Harder, Lena; Marovca, Blerim; Cario, Gunnar; Eckert, Cornelia; Schrappe, Martin; Stanulla, Martin; von Stackelberg, Arend; Bourquin, Jean-Pierre; Bornhauser, Beat C (2016). Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL. Science Translational Medicine, 8(339):339ra70.

Möricke, Anja; Zimmermann, Martin; Valsecchi, Maria Grazia; Stanulla, Martin; Biondi, Andrea; Mann, Georg; Locatelli, Franco; Cazzaniga, Giovanni; Niggli, Felix; Aricò, Maurizio; Bartram, Claus R; Attarbaschi, Andishe; Silvestri, Daniela; Beier, Rita; Basso, Giuseppe; Ratei, Richard; Kulozik, Andreas E; Lo Nigro, Luca; Kremens, Bernhard; Greiner, Jeanette; Parasole, Rosanna; Harbott, Jochen; Caruso, Roberta; von Stackelberg, Arend; Barisone, Elena; Rössig, Claudia; Conter, Valentino; Schrappe, Martin (2016). Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood, 127(17):2101-2112.

Peters, Christina; Schrappe, Martin; von Stackelberg, Arend; Schrauder, André; Bader, Peter; Ebell, Wolfram; Lang, Peter; Sykora, Karl-Walter; Schrum, Johanna; Kremens, Bernhard; Ehlert, Karoline; Albert, Michael H; Meisel, Roland; Matthes-Martin, Susanne; Güngör, Tayfun; Holter, Wolfgang; Strahm, Brigitte; Gruhn, Bernd; Schulz, Ansgar; Woessmann, Wilhelm; Poetschger, Ulrike; Zimmermann, Martin; Klingebiel, Thomas (2015). Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial. Journal of Clinical Oncology, 33(11):1265-1274.

Bandapalli, Obul R; Schuessele, Stephanie; Kunz, Joachim B; Rausch, Tobias; Stütz, Adrian M; Tal, Noa; Geron, Ifat; Gershman, Nava; Izraeli, Shai; Eilers, Juliane; Vaezipour, Nina; Kirschner-Schwabe, Renate; Hof, Jana; von Stackelberg, Arend; Schrappe, Martin; Stanulla, Martin; Zimmermann, Martin; Koehler, Rolf; Avigad, Smadar; Handgretinger, Rupert; Frismantas, Viktoras; Bourquin, Jean Pierre; Bornhauser, Beat; Korbel, Jan O; Muckenthaler, Martina U; Kulozik, Andreas E (2014). The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse. Haematologica, 99(10):e188-e192.

Eckert, Cornelia; Henze, Günter; Seeger, Karlheinz; Hagedorn, Nikola; Mann, Georg; Panzer-Grümayer, Renate; Peters, Christina; Klingebiel, Thomas; Borkhardt, Arndt; Schrappe, Martin; Schrauder, André; Escherich, Gabriele; Sramkova, Lucie; Niggli, Felix; Hitzler, Johann; von Stackelberg, Arend (2013). Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group. Journal of Clinical Oncology, 31(21):2736-2742.

This list was generated on Mon Oct 22 05:46:17 2018 CEST.